Amgen To Present At The 15th Annual Citi BioPharma Conference
THOUSAND OAKS, Calif., Sept. 4, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Citi's 15th Annual Virtual BioPharma Conference at 2:25 p.m. ET on Thursday, Sept. 10, 2020. Murdo Gordon, executive vice president of Global Commercial Operations at Amgen and Peter H. Griffith, executive vice president and chief financial officer, will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com, under Investors. A replay of the webcast will also be available on Amgen's website for at least 90 days following the event.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
CONTACT: Amgen, Thousand Oaks
View original content to download multimedia:http://www.prnewswire.com/news-releases/amgen-to-present-at-the-15th-annual-citi-biopharma-conference-301124644.html
Company Codes: NASDAQ-NMS:AMGN